ATNM
Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (ATNM)
$59
About Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (ATNM)
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or refractory cancer patients. The company was founded in 2000 and is headquartered in New York, NY.
Details
Daily high
$1.69
Daily low
$1.56
Price at open
$1.69
52 Week High
$8.64
52 Week Low
$1.03
Market cap
51.8M
Dividend yield
0.00%
Volume
115,335
Avg. volume
253,226
P/E ratio
-1.13
Actinium Pharmaceuticals, Inc. (Delaware) Common Stock News
Details
Daily high
$1.69
Daily low
$1.56
Price at open
$1.69
52 Week High
$8.64
52 Week Low
$1.03
Market cap
51.8M
Dividend yield
0.00%
Volume
115,335
Avg. volume
253,226
P/E ratio
-1.13